Veterinary Clostridium Vaccine Market Overview
The veterinary clostridium vaccine market is expected to register a CAGR of 4.8% over the forecast period. Veterinary clostridium vaccines are used for the prevention of clostridial diseases in animals, owing to the fact that the disease prevention relies majorly on vaccination only. Clostridial diseases are caused by anaerobic bacteria, which are widespread in the environment, particularly in soil, and these causative agents are mostly fatal. Rising consumption of animal-derived products, increasing incidences of clostridial diseases, and increase in disposable income and spending on livestock animal are contributing to the market growth. However, high dependence on government distribution channel, side effects associated with vaccines, and high cost of the treatment can adversely affect the market growth.
Growing Incidences of Clostridial Diseases to Fuel the Growth of Veterinary Clostridium Vaccine Market
Rise in prevalence of various forms of clostridial diseases in production animals, such as cattle, sheep, swine, poultry, etc. are expected to propel the market growth. Clostridial diseases have always been widely prevalent in North America and Europe for decades, and now its prevalence is rising in Asia. For example, in Ontario, Canada, a growth has been recorded in the number of cases of clostridial disease in dairy cattle, primarily caused by Clostridium septicum and Clostridium chauvoei, over the recent years. Each year, there are a huge number of outbreaks taking place in calves at pasture in Canada, owing to the fact that it is highly abundant in the soil in some locations. Clostridial diseases involve a variety of symptoms, including tetanus, blackleg, black disease, malignant oedema, pulpy kidney, and botulism. Full postmortem services for livestock animals are provided by both the APHA (Animal and Plant Health Agency) and Scotland’s Rural College. As per their report published in 2017, cases of clostridial disease diagnosed by the APHA services in 2016, based on the causative agents, were as follows: C. sordelli – 9%, C. botulinum – 9%, C. chauvoei – 38%, C. novyi – 15%, C. septicum – 6%, C. perfringes – 23%.
In addition to the aforementioned factor, the rising consumption of animal-derived products, and increase in disposable income, and spending on livestock animal are expected to fuel the growth of the veterinary ultrasound devices market over the forecast period.
Side Effects Associated with Vaccines are Restraining the Growth of Veterinary Clostridium Vaccine Market
Various side effects associated with the administration veterinary clostridium vaccines, used to prevent various clostridial diseases in livestock animals, are expected to restrain the growth of the veterinary clostridium vaccine market. Some of the presently marketed clostridial vaccines lead to a temporary lump or swelling at the injection site (injection site reactions). The most common side effects are caused by clostridial bacterins, which contain whole organisms. According to the American Journal of Veterinary Research (AJVR), firm injection site swellings develop in livestock animals (mainly cattle), upon the administration of vaccines either via subcutaneous injection or via transdermal needle-free injection. However, the swellings are often observed to be significantly smaller in cattle, which are vaccinated transdermally. In addition, skin discoloration at the injection site may take place. Sometimes, in case of severe anaphylactic reactions, the veterinarians don not get a chance to treat the animal, leading to its death. However, in less serious situations, the affected animals can be treated with intravenous epinephrine. The problem often faced is that the veterinarians do not have this drug on hand.
In addition to the aforementioned factors, the high dependence on government distribution channel, and the high cost of the treatment are some other major factors, which can restrain the growth of the market.
Asia-Pacific to Show Lucrative Growth in the Veterinary Clostridium Vaccine Market
Asia-Pacific is expected to show high growth rate in the veterinary clostridium vaccine market over the forecast period, owing to the factors, such as large livestock population. According to the National Dairy Development Board, India’s total livestock population in India, as recorded in 2012, is around 512 million. The regulation of veterinary healthcare products in India is under the Department of Animal Husbandry (DAH), which is under the Ministry of Agriculture (MoA). The products for animal health use are regulated and licensed by the Drug Controller General of India (DCGI), which is under the Central Drugs Standard Control Organization (CDSCO). Even after having such a large livestock production, India ranks 13th in the animal drugs market, generating a huge scope for fast growth.
In addition, rise in awareness regarding health of livestock animals, and advancement in innovation of drugs are driving the growth of the veterinary clostridium vaccine in Asia-Pacific.
Key Developments in the Veterinary Clostridium Vaccine Market
- Jan 2017: Pfizer announced positive top-line results from phase 2 study of investigational Clostridium difficile vaccine for the prevention of C. difficile infection.
Major Players: Boehringer Ingelheim, Bayer AG, Ceva, Colorado Serum Company, Virbac, Valneva SE, Merck & Co. Inc., and Zoetis Services LLC, among others.
Veterinary Clostridium Vaccine Market Report Summary
Veterinary Clostridium Vaccine Market
2018 – 2023
Largest Market Share by Region
Jan 2017: Pfizer announced positive top-line results from phase 2 study of investigational Clostridium difficile vaccine for the prevention of C. difficile infection
Boehringer Ingelheim, Bayer AG, Ceva, Virbac, Merck & Co. Inc., and Zoetis Services LLC, among others
Veterinary clostridium vaccine market report offers latest trends, growth prospects, industry competitiveness, major players, value/supply chain, regional market share, and forecast to 2023.
Reasons to Purchase the Veterinary Clostridium Vaccine Market Report
- Analyzing various perspectives of the global veterinary clostridium vaccine market with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3-months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Veterinary Clostridium Vaccine Market Report
- This report can be customized to meet your requirements. Please connect with our representative who will ensure you that get a report that suits your needs
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis
6.1 Market Drivers
6.1.1 Rising Consumption of Animal-derived Products
6.1.2 Growing Incidences of Clostridial Diseases
6.1.3 Increase in Disposable Income and Spending on Livestock Animal
6.2 Market Restraints
6.2.1 High Dependence on Government Distribution Channel
6.2.2 Side Effects Associated with Vaccines
6.2.3 High Cost of the Treatment
6.4 Key Challenges
7. Market Segmentation
7.1 By Animal Type
7.1.5 Other Animals
7.2 By Distribution Channel
7.2.1 Veterinary Clinic
7.2.2 Veterinary Hospital
7.2.3 Veterinary Research institute
7.2.4 Other Distribution Channels
7.3 By Geography
7.3.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest Of Europe
18.104.22.168 Australia & New Zealand
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
7.3.4 Middle East & Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle East & Africa
7.3.5 South America
220.127.116.11 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Boehringer Ingelheim
9.2 Bayer AG
9.4 Colorado Serum Company
9.6 Valneva SE
9.7 Merck & Co. Inc.
9.8 Zoetis Services LLC
*List Not Exhaustive
10. Future of the Market